An Analysis of the Transformation of Mega-Pharma’s Business Model toward the Emerging Market
Citations
79 citations
12 citations
Cites background from "An Analysis of the Transformation o..."
...Another factor that distinguishes the state, as potential, is to have the best result in the national high school evaluation [22]....
[...]
2 citations
1 citations
References
31 citations
"An Analysis of the Transformation o..." refers background in this paper
...Differding analyzed new chemical entity (NCE) development efforts by Indian pharmaceutical companies [1]....
[...]
...He also found current projects are targeting increasingly best-in-class compounds rather than first-in-class drugs [1]....
[...]
27 citations
"An Analysis of the Transformation o..." refers background in this paper
...Based on his own study Horner found Indian pharmaceutical industry’s adaptation rely on broader institutional setting [4]....
[...]
...Horner analyzed Indian pharmaceutical firm’s business after a product patent was introduce in India [4]....
[...]
13 citations
"An Analysis of the Transformation o..." refers background in this paper
...According to IBEF, the Indian pharmaceutical industry has many strong points: Cost advantage; Skilled manpower; National Health Policy 2015 of India; Reduction of approval time for new facilities; Increasing penetration of health insurance [13, 14]....
[...]
11 citations
"An Analysis of the Transformation o..." refers background in this paper
...Gapakumar G Nair, et al, also noticed that there have been mixed reactions from developed and developing countries & NGOs with regard to the world-class judgment from the Supreme Court of India and Controller General of Patents, Designs & Trade Marks of India [2]....
[...]
...Gapakumar G Nair, et al, selected several so-called “Landmark” patent litigation cases in India and analyzed the development and court decisions of these cases [2]....
[...]
5 citations
"An Analysis of the Transformation o..." refers background in this paper
...They also found these Indian pharmaceutical firms have been pouring significant amount of capital into R&D and actively applying for patents [5]....
[...]